Get started
BIONTECH SE DRNBIONTECH SE DRNBIONTECH SE DRN

BIONTECH SE DRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

B1NT34 trade ideas

BioNtech SE(Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # BioNtech SE(Extended Hours) - Double Formation * Neckline At 88.00 | Double Bottom Confirmation | Subdivision 1 * Support=0 | Failed Target | No Trade - Triple Formation * WXY Wave | Range Structure | Subdivision 2 * Retracement | 0.5 & 0.382 * Trade Execution | Alignment(Short) | Subdivision 3 Active Sessions On Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusion | Trade Plan Execution & Risk Management On Demand; Overall Consensus | Buy
CAPITALCOM:BNTXLong
by TradePolitics
BioNtech SE (Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # BioNtech SE (Extended Hours) - Triple Formation * Inverted Head & Shoulders | Subdivision 1 * 012345 | Failed Attempt | No Trade! * Triangle Structure | Bearish Continuation | Subdivision 2 - Double Formation * Retracement | 0.5 | Uptrend Bias * Second Shoulder | Subdivision 3 Active Sessions On Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusion | Trade Plan Execution & Risk Management On Demand; Overall Consensus | Buy
CAPITALCOM:BNTXLong
by TradePolitics
BNTX’s Next ChapterBioNTech is building strong bullish momentum, with a gap forming around the $93.00 level. A breakout above the $125.83 resistance would confirm further upward movement, positioning the stock to target the $172.41 gap-fill resistance. This trade offers an attractive risk-to-reward ratio, with a stop-loss set at $90.00 to effectively manage downside risk. BioNTech’s continued advancements in mRNA technology, along with its expanding pipeline of vaccines and immunotherapies, bolster its long-term growth potential. As the company diversifies beyond COVID-19 vaccines into oncology and infectious diseases, it remains a leader in the biotechnology sector. Increasing partnerships and new product developments further support BioNTech’s upward trajectory. With a combination of technical momentum and robust fundamentals, BNTX is well-positioned to reach $172.41, making it an appealing opportunity for investors and traders alike. NASDAQ:BNTX
NASDAQ:BNTXLong
by The_Trading_Mechanic
Target still on Both MRNA and BNTX reversed on Friday Engulfing day with decent volume ( and shorts squeeze). The selling was based on playing with the PFE news which effectively was a real no news ( no change in guidance 23 and 24 nobody knows ). In the meantime wastewater traces and hospitalisations for respiratory issues are on the rise worldwide. Cancer vaccines are moving fast ahead. As for 23 my best guess is that both MRNA and BNTX will meet their guidance. So all in all COVID vaccines market will be around USD 18 bil this year.
NASDAQ:BNTXLong
by model421
BioNTech prepping for major upside to 138Inv Head and Shoulders seems to be forming on BioNTech company listed on the Nasdaq. We might have a consolidation period for the final shoulder to form before it breaks up and out of it. There is also a solid uptrend, which the price continues to make higher lows. With the price staying above the 200MA will help the bullish momentum send it to the first target of $138.36. Let's see how it plays out as it's still a bit early before jumping in.
NASDAQ:BNTXLong
by Timonrosso
BNTX Flexibilty during a transitional period.Following last ER, I was impressed by BNTX capacity to flex its costs i.e business model (notably vs MRNA) to keep being profitable. Now 17 Bil. in cash. Also believe it was conservative on its modified 2023 guidance compared with PFE ( one is wrong imo). So i believe it is still a cheap stock trading around 30 net of cash (back to before Covid). It filled the small gap (orange box). I expect it to test 125 again. Then it will be up to the cancer treatment narrative.
NASDAQ:BNTXLong
by model421
BionTech Fastly Approaching Major Resistance, Will we Break?Hi Guys, this is a Technical Analysis on BionTech (BNTX) on the 3 Day Timeframe. We are currently approaching a MAJOR RESISTANCE Trendline. This Trend started from the TOP in 08/2021. Everytime we've interacted with it in the past, we've been REJECTED. Will we get Rejected again? Well, we've had 3 touch points already. In trendline theory, it states that atleast 3 touches are required before a trendline is weak enough to break through. So, it is possible that a break can occur. With risk of new variants, hospitalizations of COVID increasing and a push of government to get people to get boosters, this could be a chance for Trend change to UPSIDE for BNTX. BUT just looking at it in a pure TA lens, i wouldn't just start buying now. I would wait for a break above the Trendline and CONFIRMATION above it. Also with the break, note that VOLUME should be spiking and increasing. We should not see a DECLINE in Volume as we break through. That can be signs of a FAKEOUT. We are also reaching some Resistance from a Support line turned Resistance line. Now lets look at our indicators for more evidence. RSI -> We've had the Lowest RSI reading on May 09,2023 EVER in BNTX history. This could be a catalyst for more buying pressure and a trend change. We also broke above RSI Red Resistance line. MACD-> A momentum indicator, has crossed BULLISH, below the 0 level. If we continue this bullish momentum and the Blue/Orange lines move above the 0 level, this can be inject the well needed momentum for BNTX to increase in price. STOCH RSI -> Is also in a BUllish cross and it shows that theres plenty of room for momentum to continue. __________________________________________________________________________________ Thank you for taking the time to read my analysis. Hope it helped keep you informed. Please do support my ideas by boosting, following me and commenting. Thanks again. Stay tuned for more updates on BNTX in the near future. If you have any questions, do reach out. Thank you again. DISCLAIMER: This is not financial advice, i am not a financial advisor. The thoughts expressed in the posts are my opinion and for educational purposes. Do not use my ideas for the basis of your trading strategy, make sure to work out your own strategy and when trading always spend majority of your time on risk management strategy.
NASDAQ:BNTX
by SafofAllTrades
2
BNTX biotech / currency play LONGBNTX a Germany company in the biotechnology and vaccine sectors out of Europe and Germany is looking good on the 2H chart here with a volume profile and an intermediate term VWAP overlaid. Price bounced off the bottom of the high volume area of the volume profile and looks to be ready for a reversion to the mean and even a sling-short move. The target here is the double top M pattern of mid July at 114. The VPT and MACD are confirmatory of a momentum flip making for a long trade entry. I will review the options chain for a suitable options trade with a narrow bid/ask spread, suitable volume and open interest. If I cannot find one I'll take a trade of 10-20 shares of stock with a stop-loss of 105 to back up this trade while NVAX and MRNA are also making moves.
NASDAQ:BNTXLong
by AwesomeAvani
BioNTech SE : Long Term?Big news announced in Nature, news-articles etc. (Trade at your own risk!) While on a short term this stock won't probably boom that much, this news could mean a huge stock opportunity When we look at the shart we see a huge pump in the corona-period in which they also made (and still make) vaccins, this could be the next one. Although we should consider that the production, approvement for a new vaccin like this could take years and years we shouldn't underestimate what they've found here and might find in the future. Cancer treathment will always be needed and a huge dump like after corona isn't really expected. The stock being at a resistance level could really work out good here, although it might be interesting to wait for the Earnings & Revenue rapport on the 7th of August. I think the green box is safe to buy/trade in around this period, while if the stock is stumbeling around the lower resistane (orange) you really should think twice! You also could wait for them to get the vaccin approved etc. the risk you're taking here is a little bit higher than if you would wait for that but the stock price by then would ofc be normally higher than now. Another stock to watch is ROCHE I (RO) (they co-developed the vaccin). www.tradingview.com
NASDAQ:BNTXLong
by Gwoble
RectanglePrice looks to be in consolidation mode or a small triangle within a horizontal trading range. Price is been inside of the Rectangle for several months. This pattern is neutral until broken. Some would trade inside the Rectangle. This will most likely bust a move one way or the other. Earnings date conflicts between a few different sites. I see 3-29 on Trade View but I also see 2-20 BMO estimated on Earning's Whispers. ATL 10.40. ATH 461.87. No recommendation. EPS (FWD) 37.37 PE (FWD) 3.79 Div Rate (TTM) - Yield (TTM) - Short Interest 2.12% Market Cap $34.39B
NASDAQ:BNTX
by lauralea
1